Skip to main content

IDENTIFICACION DE FACTORES GENETICOS DE STAPHYLOCOCCUS AUREUS ASOCIADOS A UN MAYOR RIESGO DE BACTERIEMIA COMPLICADA MEDIANTE TECNICAS DE SECUENCIACION MASIVA (AURISEQ)

PI19/01911

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION PARC TAULI
Execution centre CORPORACION SANITARIA PARC TAULI

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Is ampicillin plus cephalosporins a therapeutic option for Ampicillin-Susceptible Enterococcus faecium?

  • Bierge, Paula|||0000-0003-0917-3445
  • Gómez-Sánchez, Inmaculada|||0000-0002-4255-0882
  • García de la Mària, Cristina|||0000-0002-0585-9469
  • Sánchez-Osuna, Miquel|||0000-0001-5267-4814
  • Capilla, Silvia|||0000-0002-7274-2973
  • Casabella Pernas, Antonio|||0000-0002-2534-3689
  • Espasa, Mateu|||0000-0003-4822-1024
  • Novais, Carla|||0000-0002-3826-6731
  • Miró, José M.|||0000-0001-8057-7755
  • Pich, Oscar Q.|||0000-0003-3561-630X
  • Gasch, Oriol|||0000-0001-8518-458X
Objectives: Enterococcus faecium, a significant hospital associated pathogen, poses substantial treatment challenges. While combinations of ampicillin with cephalosporins are first-line therapies to treat Enterococcus faecalis high-mortality-rates infections, their efficacy against ampicillin-susceptible E. faecium (ASEfm) is less clear. This study evaluates the effectiveness of combining ampicillin with ceftriaxone or ceftaroline against ASEfm strains. Methods: Ten ASEfm bloodstream isolates from complicated infections were analyzed. Susceptibility to several antibiotics, including ceftriaxone, ceftaroline, and cefotaxime, was determined using standard methods. Time-kill assays were conducted to assess the synergistic and additive effects of ampicillin in combination with ceftriaxone or ceftaroline. Results: Time-kill studies revealed that ampicillin combined with ceftaroline demonstrated synergistic and/or additive effects in 7 out of 10 strains analyzed. In contrast, ampicillin combined with ceftriaxone showed less pronounced synergy, with only 3 out of 10 strains exhibiting synergistic and/or additive effects. Conclusions: Our findings indicate that ampicillin combined with ceftaroline, or ceftriaxone provides synergistic activity against some but not all ASEfm clinical isolates. The observed synergy suggests that these combinations could offer a potential therapeutic option for challenging ASEfm infections.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Metal utilization in genome-reduced bacteria, Do human mycoplasmas rely on iron?

  • Peralvarez-Marin, Alex|||0000-0002-3457-0875
  • Baranowski, Eric|||0000-0003-0660-1854
  • Bierge, Paula|||0000-0003-0917-3445
  • Pich, Oscar Q.|||0000-0003-3561-630X
  • Lebrette, Hugo
Mycoplasmas are parasitic bacteria with streamlined genomes and complex nutritional requirements. Although iron is vital for almost all organisms, its utilization by mycoplasmas is controversial. Despite its minimalist nature, mycoplasmas can survive and persist within the host, where iron availability is rigorously restricted through nutritional immunity. In this review, we describe the putative iron-enzymes, transporters, and metalloregulators of four relevant human mycoplasmas. This work brings in light critical differences in the mycoplasma-iron interplay. Mycoplasma penetrans, the species with the largest genome (1.36 Mb), shows a more classic repertoire of iron-related proteins, including different enzymes using iron-sulfur clusters as well as iron storage and transport systems. In contrast, the iron requirement is less apparent in the three species with markedly reduced genomes, Mycoplasma genitalium (0.58 Mb), Mycoplasma hominis (0.67 Mb) and Mycoplasma pneumoniae (0.82 Mb), as they exhibit only a few proteins possibly involved in iron homeostasis. The multiple facets of iron metabolism in mycoplasmas illustrate the remarkable evolutive potential of these minimal organisms when facing nutritional immunity and question the dependence of several human-infecting species for iron. Collectively, our data contribute to better understand the unique biology and infective strategies of these successful pathogens.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Genomic analysis of Staphylococcus aureus isolates from bacteremia reveals genetic features associated with the COVID-19 pandemic

  • Sánchez-Osuna, Miquel|||0000-0001-5267-4814
  • Pedrosa, Marc|||0000-0001-6355-4121
  • Bierge, Paula|||0000-0003-0917-3445
  • Gómez-Sánchez, Inmaculada|||0000-0002-4255-0882
  • Alguacil Guillen, Marina|||0000-0003-1530-013X
  • Espasa, Mateu|||0000-0003-4822-1024
  • Erill, Ivan|||0000-0002-7280-7191
  • Gasch, Oriol|||0000-0001-8518-458X
  • Pich, Oscar Q.|||0000-0003-3561-630X
Genomic analyses of bacterial isolates are effective to compare the prevalence of antibiotic resistance genes and virulence determinants in different contexts. This study provides a comprehensive genomic description of 339 Staphylococcus aureus strains isolated from patients with bacteremia (2014-2022). Nosocomial acquisition accounted for 56.6% of cases, with vascular catheters being the main infection source (31.8%). Fatality (27.4%), persistent bacteremia (19.5%), and septic emboli (24.2%) were documented. During the COVID-19 pandemic, S. aureus bacteremia episodes increased by 140%. Genetic features in pandemic isolates revealed higher prevalence of methicillin (mecA) and macrolide (msrA and mphC) resistance genes. Additionally, genes encoding clumping factors A and B, involved in fibrinogen binding, were more prevalent. This was linked to extensive macrolide use in COVID-19 accessory therapy and elevated fibrinogen levels in SARS-CoV-2 infection. These findings highlight S. aureus adaptation to COVID-19 selective pressures and the value of whole-genome sequencing in molecular epidemiology studies.